Literature DB >> 7206730

[Platelet aggregation and platelet activating factor (author's transl)].

M Chignard, B B Vargaftig, J Benveniste, J P Le Couedic.   

Abstract

Platelet aggregation is triggered by at least three distinct pathways. The first one is mediated by adenosine diphosphate, the second one by arachidonic acid metabolites and the third is defined somehow by exclusion of the first two. In fact rabbit platelets synthesize, during their activation, another substance with potent aggregating activity, namely platelet-activating factor or PAF-acether. Indirect pieces of evidence are presented, which suggest that PAF-acether is the mediator of the third pathway of platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7206730

Source DB:  PubMed          Journal:  J Pharmacol        ISSN: 0021-793X


  5 in total

Review 1.  Biology and biochemistry of platelet-activating factor.

Authors:  J T O'Flaherty; R L Wykle
Journal:  Clin Rev Allergy       Date:  1983-09

2.  Experimental Trypanosoma cruzi cardiomyopathy in BALB/c mice. The potential role of intravascular platelet aggregation in its genesis.

Authors:  M A Rossi; S Gonçalves; R Ribeiro-dos-Santos
Journal:  Am J Pathol       Date:  1984-02       Impact factor: 4.307

3.  Acetal phosphatidic acids: novel platelet aggregating agents.

Authors:  J P Brammer; M H Maguire; E J Walaszek; R A Wiley
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

4.  Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin.

Authors:  C Lecrubier; J Conard; M H Horellou; M Samama
Journal:  Agents Actions       Date:  1983-02

5.  Glucocorticoid protection against PAF-acether toxicity in mice.

Authors:  A Myers; E Ramey; P Ramwell
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.